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ABSTRACT
Doran, Diane Michelle. M.S., Department of Biological Sciences, Program in
Microbiology and Immunology, Wright State University, 2007.
Hypoxic Induction and the Role of HIFs in the Activation of Luciferase Constitutive
Reporters in Placental Stem Cells.
Hypoxia is critically important to the development of the embryo and placenta.
Proper placental development is critical for normal fetal growth and embryonic survival.
Abnormal placental development has been implicated in numerous obstetric
complications, including preeclampsia, which affects about 7% of all pregnancies and
can be fatal for both mother and baby.
Rodent and murine trophoblast stem cells differentiate into three distinct cell
lineages: giant cells, spongiotrophoblasts, and labyrinthine cells, which form different
layers and have different functions within the placenta. Recent studies in our laboratory
have focused on the invasive giant cell layer using the rodent Rcho-1 choriocarcinoma
stem cell-like cell line, which has been shown to be committed to differentiate into the
giant cell lineage.
It has been shown that chronic exposure to hypoxia inhibits Rcho-1 trophoblast
differentiation. One factor that has been extensively studied in the field of hypoxia are
Hypoxia-Inducible Factors (HIFs), conserved, heterodimeric proteins that bind to DNA
under hypoxic conditions to up regulate oxygen-dependent gene transcription. Whereas
HIF-β (ARNT) is ubiquitously expressed and stable, HIF-α is subject to rapid turnover in
normoxia and has been the major focus in studies examining HIF regulation. Although
v
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HIF-1α has been widely studied, few studies have been done on the function of HIF-2α
in the regulation of trophoblast differentiation.
Studies in our laboratory sought to characterize the mechanism of giant cell
differentiation and placental formation and have recently focused on HIF-1α. However,
it is possible that HIF-1α and HIF-2α play complementary roles in controlling
trophoblast differentiation and placental formation in vivo, therefore this study examined
the role of HIF-2α in Rcho-1 trophoblast differentiation. Previous studies examined the
transcriptional activity of HIF-1α in response to hypoxia in the Rcho-1 trophoblast
placental stem cell line, using a conventional luciferase dual-reporter assay. However, it
was consistently observed that the level of activation of the constitutive reporter was
significantly higher in hypoxic samples than in normoxic controls; therefore, this study
also examined the role of HIF-1α in the unexpected induction of luciferase constitutive
reporters after exposure to hypoxia, using a more reliable transfection method.
The results of this study indicate that HIF-2α protein is not detectable in Rcho-1
cells, even after exposure to hypoxia. This study also found that the hypoxic induction of
luciferase constitutive reporters was a phenomenon independent of species or cell-type
and sequence analysis revealed that hypoxic induction of the luciferase constitutive
reporters was independent of HIF-1α. Sequence analysis also revealed the consensus
sequences for several other transcription factor binding sites, including steroid hormones
and NF-κB. Finally, this study demonstrates a more reliable method of controlling for
transfection efficiency that negates the need for luciferase constitutive reporters, avoiding
potential error caused by their hypoxic induction.
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INTRODUCTION
A. Hypoxia and Placental Development
Embryonic implantation and placental formation occur under severe hypoxic
conditions (~3% O2) [1-9]. Measures of oxygen tension between eight to ten weeks of
pregnancy indicate that the partial pressure of oxygen is significantly lower in the
placenta than in the surrounding endometrium (~14% O2) [10]. Furthermore, oxygen
tension slowly increases until about week 13 of pregnancy, when the partial pressure of
oxygen is approximately equal in the placenta and the endometrium [10]. Hypoxia is
important for the protection of the very early embryo from oxidative stress as the placenta
does not begin to produce superoxide dismutases until approximately the eighth week of
gestation [10]. Exposure to oxygen before this time would expose the fetus to oxidative
damage, possibly resulting in birth defects or spontaneous abortion. The formation of the
placenta from the trophoblasts occurs in a manner which protects the fetus from this
threat.
Placental development involves the interaction of fetal and maternal tissues in an
extremely complex process. In the murine blastocyst, the first two cell lineages to
develop are the trophectoderm and the inner cell mass (ICM) (Figure 1). The
trophectoderm surrounds the ICM, which becomes the fetus and has different functions
based on its relationship to the ICM [11-13]. The mural trophectoderm lies opposite, and
does not contact, the ICM. This portion of the trophectoderm differentiates into primary
giant cells which invade the maternal decidua as the site of initial attachment of the
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Figure 1: Origin of trophoblast stem cells.
The first two cell lineages that arise from the murine blastocyst are the
trophectoderm and the inner cell mass (ICM). The ICM becomes the embryo. The mural
trophectoderm differentiates into primary giant cells which invade the maternal decidua
to anchor the blastocyst. Trophoblast stem cells arise from the polar trophectoderm of
the embryo, just above the inner cell mass. Figure modified from Gultice AD, Wright
State University, 2005.
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blastocyst to the uterine lining [12-14]. Placental stem cells arise from the polar
trophectoderm of the embryo, just above the inner cell mass. After the embryo attaches
to the endometrial wall, trophoblast stem cells from the polar trophectoderm begin to
invade the maternal uterine tissue [12, 15]. The area of intimate contact between the
fetal and maternal tissues is known as the junctional zone [15]. The junctional zone is
further divided into regions, based on proximity to fetal or maternal tissues. The basal
plate lies on the embryo/fetal side of the junctional zone and the placental bed lies on the
maternal side; all trophoblast cells residing outside the placental villi are termed
extravillious trophoblasts in humans or trophoblast giant cells in rodents [15]. These
trophoblasts then differentiate to distinct lineages that represent different functional
layers within the placenta.
Proper placental development is critical for normal fetal growth and embryonic
survival [4-6]. Its invasion and attachment in the uterus serves as the maternal-fetal
interface allowing the secretion of hormones necessary to maintain pregnancy, while
providing a barrier against maternal immunological attack and mediating the exchange of
nutrients and wastes between mother and child [4-6, 16-19]. Irregular or abnormal
placental development has been implicated in numerous complications of pregnancy
including intrauterine growth retardation, spontaneous abortion, and maternal
hypertension, which can lead to a potentially fatal condition known as preeclampsia [4-6,
15, 20].
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B. Studying Trophoblast Differentiation
Cell Line Models
The placenta in rodents and humans is similar in many ways and is composed of
analogous cell types which display similar functions. Additionally, there is some
conservation between transcription factors necessary for the expression of several
placental genes and the trophoblast cell lineages appear to follow the same pathways
despite overall differences in the morphogenesis of rodent and human placentas [11, 16,
19]. Rodent and murine trophoblast stem cells differentiate into three distinct cell
lineages: giant cells, spongiotrophoblasts, and labyrinthine cells (Figure 2) [11, 16-17,
21]. These cell types express conserved genes and mediate placental formation and are
similar in function to human cell types [11, 16-19]. Due to the difficulty of studying
human placental development in vivo and of obtaining human stem cells, several rodent
and murine cell lines have been developed to study placental trophoblasts in vitro.
Previous studies in our laboratory developed a lineage profile for each of the different
cell types found in vivo and used these profiles to characterize each cell line [22].
The TS3.5 cell line, isolated from a mouse blastocyst at day 3.5 of gestation, is a
trophoblast stem cell line that can be induced to differentiate [6, 13, 22]. Lineage
analysis has shown that TS3.5 cells have the ability to differentiate into all three murine
cell types simultaneously, specifically, labyrinthine cells, spongiotrophoblasts, and giant
cells [13, 17, 22]. Studies have indicated that TS3.5 cells can be induced to differentiate
toward the giant cell lineage depending on the treatment used to induce differentiation,
however, other cell lineages may still be present in the culture making the exclusive study
of the giant cell lineage difficult [21-23].

5

Figure 2: Trophoblast stem cell lineages and functions
Rodent and murine trophoblast stem cells differentiate into three lineages with
distinct morphologies and functions. The labyrinthine layer is responsible for the
transport of wastes and nutrients across the placenta. The spongiotrophoblast layer
serves as a barrier, with no other known function while the giant cell layer is the invasive
layer, responsible for invading the maternal decidua and establishing blood flow to the
developing embryo. Analogous cell types have been identified in humans for the
labyrinthine and giant cell layers. Figure modified from Gultice et al. Biol. Reprod.
2006; 74(6): 1041-1050.
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The SM-10 cell line is another mouse trophoblast stem cell-like cell line and has
recently been reported to be committed to differentiate into the labyrinthine lineage [22,
24-25]. The labyrinthine lineage is composed of cells responsible for the transport of
nutrients, wastes, and other materials between mother and fetus. It is one of the two cell
types analogous to the human placenta, where it is called the syncytiotrophoblast, and the
lineage analysis protocol designed by our lab revealed that it does differentiate
exclusively toward the labyrinthine lineage in vitro when treated with TGF-β [16, 22, 24].
The second analogous cell type is the rodent giant cell lineage, which is
responsible for the invasion of the uterine lining and remodeling of the maternal
vasculature in order to deliver blood supply to the developing embryo [6, 11, 16, 21, 24].
A cell line that serves as a model for this lineage is the rat Rcho-1 choriocarcinoma stem
cell-like cell line. The Rcho-1 cell line, developed by Dr. Michael Soares, serves as a
model of the invasive trophoblast giant cell placental lineage and has been used
extensively [6, 22, 26]. Lineage analysis studies have characterized this cell line on the
molecular, morphological, and functional levels and determined that the Rcho-1
trophoblast stem cell line is committed to differentiate only into the invasive, giant cell
phenotype (Figure 3). This allows studies using this cell line to focus solely on the
function and importance of the giant cell placental layer.

c. Regulation of Giant Cell Differentiation
Hypoxia-Inducible Factors
Increasing levels of oxygen tension regulate the timing of trophoblast giant cell
migration, invasion and differentiation into the maternal decidua and the remodeling of
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Figure 3: Rcho-1 Trophoblasts
Rcho-1 trophoblasts are a rodent choriocarcinoma derived stem cell-like cell line
that model the invasive giant cell lineage. When differentiated, they exhibit the typical
morphological, functional, and molecular changes characteristic of giant cells including
decreased expression of Inhibitor of differentiation 2, increased expression of palladin
and chorionic sommatomammotropin hormone-1 (CSH-1), increased actin stress fiber
formation, endoreduplication, and a dramatic increase in cell size [6, 22, 26]. Cells are
shown magnified 400x. A. Rcho-1 stem cells. B. Rcho-1 differentiated cell.
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the maternal vasculature, though no study has conclusively determined the exact
mechanisms for these events [4-6, 20, 27]. It has been shown, however, that chronic
exposure to hypoxia inhibits trophoblast giant cell differentiation, suggesting that a
failure in migration or invasion may be enough to stall differentiation and cause placental
complications [4-6, 20, 27].
One factor that has been extensively studied in the field of hypoxia is a family of
oxygen-sensitive, basic helix-loop-helix transcription factors known as hypoxia-inducible
factors, or HIFs. HIFs are highly conserved, heterodimeric proteins that bind to DNA
under hypoxic conditions to up-regulate oxygen-dependent gene transcription [1-4, 6-9,
12, 27-55]. The functional heterodimer consists of a phosphorylation-dependent HIF-α
subunit and a constitutively expressed HIF-β subunit, also known as the aryl hydrocarbon
receptor nuclear translocator (ARNT). To date, studies have identified three HIF-α
homologs named HIF-1α, HIF-2α, and HIF-3α, though most studies focus on HIF-1α or
HIF-2α (also identified as Endothelial PAS1, HIF-related factor, HIF-like factor, and
MOP2) [2-4, 8-9, 28, 34-36, 38, 61-64]. Whereas HIF-1α mRNA expression is present
in most cell types, HIF-2α mRNA expression is more cell-type specific, appearing
predominantly in epithelial, neuronal, and fibroblast tissue as well as many tumors [3, 3233, 35]. HIF-2α has been shown to have about 48% sequence homology to HIF-1 with
highly conserved bHLH, PAS and oxygen degradation-dependent (ODD) domains
suggesting that the two proteins have identical regulatory mechanisms [4, 32-33, 36].
Although HIF-1α and HIF-2α are known to function as heterodimeric transcription
factors, the function of HIF-3α is still unclear. However, a short splice variant of HIF-3α,
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inhibitory PAS protein (IPAS), has been shown to function as a transcriptional repressor
[2].
Knockout studies indicate that, despite their similarity, HIF-1α and HIF-2α have
some non-redundant functions. Studies using placental stem cells from HIF-1α-/- , HIF2α-/- , and ARNT-/- mice reveal that knockout of only one HIF-α subunit results in a much
less severe placental defect than seen in a double knockout, indicating that some overlap
in function does exist. However, HIF-1α-/- mice exhibit placental blood vessel defects
while HIF-2α-/- mice exhibit abnormal lung develop and vascular defects [3, 33].
Knockdown of both HIF-α subunits together results in severe placental defects that
mimic those seen in ARNT-/- mice. In all cases, HIF-α-/- and ARNT-/- knockouts are
embryonic lethal by day 10.5 [7, 13]. HIF-α-/- and ARNT-/- also change the fate of
placental differentiation, shifting trophoblast cell fate toward less invasive cells types,
resulting in shallow invasion of the placenta into the maternal decidua and poor fetal
vascularization of the placenta. HIF-α-/- and ARNT-/- knockout in TS 3.5 cells shifts
differentiation away from the invasive giant cell phenotype toward the less invasive
labyrinthine lineage [4, 7, 13]. Despite the apparent non-redundancy of function between
HIF-1α and HIF-2α and its cell-type specificity, few studies have been done to elucidate
the functional role of HIF-2α in trophoblast differentiation or its role in placental
formation independent of HIF-1α. It has been reported, however, that HIF-2α is present
in vascular endothelial cells within the placenta [7, 33, 35, 37].
HIF-α subunits are continually expressed in most human tissues but are very
rapidly degraded under normal oxygen and metabolic conditions through the ubiquitindependent proteasomal degradation pathway [2-9, 7, 9, 12, 28-32, 43-47, 51-53, 55]. The
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Figure 4: HIF-α subunit
HIF-1α and HIF-2α are 48% conserved overall but are nearly identical in the Per
ARNT Sim (PAS) domain, oxygen-dependent degradation domain, and the
transactivation (TA) domains. The HIF-α subunit is represented graphically along with
the conserved amino acids that are hydroxylated to regulate its stability and activity, two
prolines (P) in the oxygen-dependent degradation domain (ODD) and an asparagine (N)
in the C-terminal transactivation domain (CTAD). Figure modified from Wenger, et al,
Sci. STKE, 2005.
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HIF-β heterodimer partner is ubiquitously expressed and stable in most cell types [3, 29,
38, 40, 45, 51-53]. The HIF-α and β subunits must dimerize in order for the HIF protein
to be functionally active. Whereas HIF-β is constitutively expressed and not subject to
hypoxic regulation, HIF-α contains several functional domains, including the oxygendependent degradation domain (ODD) and the C-terminal transactivation domain
(CTAD), whose modification allows for the hypoxic regulation of the protein (Figure 4)
[2-3, 36, 38, 40, 43, 51-52, 70]. Under normal oxygen conditions, key proline and
asparagine residues within the ODD and CTAD of the α-subunit are hydroxylated by
prolyl and asparaginyl hydroxylases (PHD2 and Factor-Inhibiting HIF (FIH),
respectively), targeting HIF-α for ubiquitination and degradation through interactions
with the von Hippel-Lindau tumor suppressor protein (VHL) [2, 4, 9, 32, 36-39, 47-49,
51-53]. Prolyl hydroxylases require both Fe(II) and dioxygen as cofactors. If one of
these cofactors is removed, the enzyme is unable to act, allowing HIF-α to escape
degradation. Therefore, during hypoxic conditions, hydroxylation and ubiquitination are
blocked due to the lack of available oxygen, causing the HIF-α subunit to stabilize and
allowing it to dimerize with the HIF-β subunit and recruit co-factors, such as p300, to
become transcriptionally active (Figure 5) [2-4, 12, 29-30, 36, 39, 43, 48, 51-52, 55].
Interestingly, VHL-/- and PHD2-/- mice, which have an abundance of HIF-α, are also
embryonic lethal due largely to defects in the placenta [9, 12, 50, 56]. Similar to results
seen with HIF-1α and ARNT knockdown, PHD2-/- , which increases HIF-α levels, also
shifts TS cell differentiation toward the labyrinthine lineage [4, 7, 9, 12]. Additionally,
increased levels of HIF-1α and HIF-2α protein expression have been observed in tissue
samples from pre-eclamptic placentas [4, 20]. This paradox underscores the complexity
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Figure 5: HIF-α subunit degradation and stabilization.
Under normal oxygen conditions, the HIF-α subunit is hydroxylated at conserved
proline and asparagine residues in the oxygen-dependent degradation domain and Cterminal transactivation domain by PHD2 and FIH. The hydroxylation targets HIF-α for
ubiquitination by VHL. Polyubiquitination then targets HIF-α for degradation in the
proteasome. Low oxygen levels inhibit the action of PHD2 and FIH, allowing the HIF-α
subunit to escape degradation. It is then able to dimerize with HIF-β (ARNT), recruit
cofactors such as p300/CBP, and bind to HREs in the DNA, activating hypoxiaresponsive genes. Figure was modified from Bhattacharya and Ratcliffe, Nat. Struct.
Biol., 2003, 10(7): 501-503.
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of placental development and indicates that proper regulation of HIF levels is critical for
correct development of the placenta [12].
The functional HIF protein binds to Hypoxia Response Elements (HREs) located
within the promoter regions of genes necessary for cell survival under low oxygen
conditions, including genes involved in angiogenesis and glycolysis such as
erythropoietin (EPO), phosphoglycerate kinase-1 (PGK), and vascular endothelial growth
factor [3, 5-6, 28-29, 33-34, 50, 52-55, 57-60]. Because a number of cofactors are
necessary for HIFs to be transcriptionally active, including p300/CBP, when
working with HIFs it is important to assay for transcriptional activity as well as the
presence of protein [2, 44, 51]. For example, in 2003, Hu et al reported that though HIF2α protein had been observed in murine ES and mouse embryonic fibroblasts and was
able to heterodimerize with HIF-β and bind to HREs, the protein was nonfunctional as a
transcription factor due to binding of a repressor protein [33]. Western blotting, which
can estimate relative amounts of stable protein in cell extracts, cannot be used alone to
analyze the activity of HIFs. Therefore, a more direct measure must be used to analyze
the effects of treatment on HIF activity. One of the easiest ways this can be
accomplished is through luciferase reporter assays, which measure the activity of
luciferase reporter genes under the control of a target promoter to represent the upregulation of HIF target genes as an indication of HIF transcriptional activity.

D. Previous Studies
Studies in our laboratory sought to characterize the mechanism of giant cell
differentiation and placental formation. Previous studies in our lab and others have
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determined that Rcho-1 cells are committed to differentiating solely into trophoblast giant
cells and can serve as a model cell line for this process. Further, studies in our laboratory
identified hallmarks of giant cell differentiation on the molecular, morphological, and
function levels, providing concrete endpoints for the study of differentiation [6, 22].
These five endpoints are 1) decreased expression of Inhibitor of Differentiation-2 (Id-2),
2) induction of palladin protein, 3) induction of chorionic sommatomammotropin
hormone-1 (CSH-1), 4) a dramatic increase in cell size, and 5) the rearrangement of the
actin cytoskeleton [6].
Using these endpoints, Gultice et al investigated the effect of hypoxia on Rcho-1
giant cell trophoblast differentiation in vitro [6]. They found that hypoxia inhibited the
differentiation of Rcho-1 trophoblasts. At 3% O2, there was very little decrease in Id-2
expression, no induction of palladin, and no significant change in cell size or
cytoskeleton arrangement, despite a seven day treatment under differentiating conditions
as described in Materials and Methods. Cells differentiated for seven days in 5% and 8%
O2 showed increasing levels of palladin induction, decreasing levels of Id-2 expression,
and increasing cytoskeletal rearrangement, though levels were still below those seen in
cells differentiated at 21% O2 [6].
These findings led to the hypothesis that HIF was involved in the regulation of
trophoblast differentiation. Indeed, elevated levels of HIF-1α protein were found in cells
cultured in differentiating conditions at 3% O2 as compared to 21% O2 control samples
and the level of HIF-1α protein induction steadily decreased as oxygen percentage
increased. Additionally, studies done using a dual-luciferase assay with the PGK-1-HRE
experimental luciferase reporter, a luciferase reporter gene under the control of the HIF-1
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specific-hypoxia response element from phosphoglycerate kinase-1, or the EPO-HRE
experimental luciferase reporter, a luciferase reporter gene under the control of hypoxia
response element from the erythropoietin gene, which has been shown to be
preferentially up-regulated by HIF-2, showed a significant induction of experimental
reporters when transfected cells were cultured at 3% oxygen [28-29]. The level of
induction dropped at higher percentages of oxygen, in correlation with the level of HIF1α protein observed.

E. Present Study
1. HIF-2α.
The initial objective of this study was to determine the role of HIF-2α in Rcho-1
trophoblast differentiation. Because placental formation is tightly regulated by HIFs, it is
possible that HIF-1α and HIF-2α play complementary roles in controlling trophoblast
differentiation and placental formation in vivo. However, very few studies have been
done on HIF-2α in trophoblast stem cells. At least one study failed to detect HIF-2α
mRNA is TS cells, though mRNA levels increased after differentiation [7]. However, the
levels of HIF-2α protein and transcriptional activity were not studied. Similarly, several
other studies have reported that HIF-2α is not functional in murine ES cells, possibly due
to its specific tissue localization [3, 33]. Preliminary studies by Gultice et al have shown
that HIF-2 mRNA is expressed at all levels of oxygen tension (data not shown), though it
is unclear if protein levels correlate with this observation. Therefore, the first aim was to
examine HIF-2α protein levels in Rcho-1 trophoblasts cultured at various levels of
oxygen by Western blot. Further, characteristic transcriptional activity at each oxygen
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level was to be determined via the luciferase assay using the EPO-HRE luciferase
reporter.
During the course of this investigation it was found that HIF-2α protein is not
present at detectable levels in Rcho-1 trophoblasts cultured in hypoxia, even though high
levels of HIF-1α were detected. Because the EPO-HRE experimental reporter is not
specific to HIF-2α, only preferential, transcriptional activity of HIF-2α could not be
determined due to the high levels of HIF-1α observed.

2. Luciferase constitutive reporters.
Previous studies also sought to examine the transcriptional activity of HIF-1α in
response to hypoxia in the Rcho-1 trophoblast placental stem cell line, using a
conventional luciferase dual-reporter assay [6]. Luciferase dual-reporter assays are
widely used in a variety of scientific fields to study transcriptional activation [61-64]. In a
conventional luciferase dual-reporter assay, cells are transfected with a firefly (Photinus
pyralis) luciferase gene under the control of a promoter region from a gene of interest and
a Renilla (Renilla remiformis) luciferase gene under the control of the promoter region
that is constitutively expressed. The two different types of luciferase commonly used
have evolutionarily distinct chemical reactions, producing different wavelengths of
fluorescence, thus allowing them to be quantified sequentially from a single sample
(Figure 6). As experiments are typically performed on independently transfected plates,
it is necessary to account for differences in transfection efficiency between plates before
results can be analyzed. This is generally accomplished by normalizing the amount of
luciferase produced by the experimental firefly luciferase reporter to the amount of
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Figure 6: Firefly and Renilla luciferase reporters and their biochemical reactions.
A. Experimental luciferase reporters consist of the firefly luciferase gene under the
control of the promoter region from a target gene that is affected by treatment. Control
luciferase reporters consist of the Renilla luciferase gene under the control of a promoter
from a gene that can be constitutively active in mammalian cells but not affected by
treatment. Activation of the promoter regions leads to transcription of the luciferase gene
and the accumulation of luciferase. B. The firefly and Renilla luciferase genes are
evolutionarily distinct and fluoresce in response to different substrates. This allows both
luciferase products to be obtained sequentially from a single sample when using a dualluciferase assay. Firefly luciferase is quantified first using an oxidizing substrate. This
reaction is quenched and the Renilla luciferase is quantified with Stop and Glo reagent
[70].
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luciferase produced by the constitutive Renilla luciferase reporter in each treatment [6566].
Three commercially available luciferase reporters are commonly used as
normalizing reporters due to their constitutive activity within most cells types. The pRLSV40 luciferase reporter (GenBank accession number AF025845) is composed of the
Renilla luciferase gene under the control of the constitutively active simian-virus 40
(SV40) early enhancer/promoter. Similarly, the pRL-CMV and pRL-TK (GenBank
accession numbers AF025843 and AF025846, respectively) are composed of the Renilla
luciferase gene under the control of the constitutively active immediate/early
promoter/enhancer of cytomegalovirus (CMV) and herpes simplex virus thymidine
kinase (HSV-TK), respectively [65-70]. Several other genes that are commonly used as
control reporters for transfection studies are also under the control of a constitutively
active CMV or SV40 promoters, including the enhanced green fluorescent protein
(EGFP)-N1 plasmid and the lacz plasmid [67-68, 71].
However, during the course of this study, it was consistently observed that the
level of activation of the constitutive reporter was significantly higher in hypoxic samples
than in normoxic controls. The activation of constitutive reporters has been previously
observed in response to steroid treatment, stimulation with lipopolysaccharide, GATA
transcription factors, and stress-activated MAP protein kinases [65-69, 71-73].
Therefore, the effect of hypoxia on constitutive luciferase reporters was also examined.
Using a more reliable split transfection protocol, this study determined that the hypoxic
induction of luciferase constitutive reporters was not species-specific or cell-type
dependent. Further, examination of the promoter regions of the luciferase constitutive
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reporters determined that no HREs were present, suggesting that HIF-1 was not directly
involved in the hypoxic induction of the luciferase constitutive reporters. Further studies
are needed to clarify the exact mechanism of hypoxic induction but this study has
demonstrated the importance of using the more reliable split-transfection assay regardless
of treatment conditions.
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MATERIALS AND METHODS
A. Materials
RPMI 1640 with L-glutamine (RPMI), Dulbecco’s Modified Eagle Medium
(DMEM), 1x Dulbecco’s Phosphate Buffered Saline (PBS), and 2-mercaptoethanol were
purchased from Fisher Scientific. Fetal Bovine Serum (FBS) was purchased from
BioWest. HEPES buffer, Trypsin-EDTA, and antibiotic-antimycotic were purchased
from Invitrogen. Sodium pyruvate solution was purchased from VWR. NXTRACT
CelLytic™ NuCLEAR™ Extraction Kit was purchased from Sigma-Aldrich. Rabbit
polyclonal HIF-1α, rabbit polyclonal HIF-2α and mouse monoclonal HIF-2α antibody
(NB100-449, NB100-122, NB100-132) were purchased from Novus Biologicals. Antirabbit horseradish peroxidase-conjugated secondary antibody was purchased from BD
Transduction. Supersignal West Pico Chemiluminescent substrate was purchased from
Pierce. Desferroxamine (DFO) and cobalt chloride (CoCl2) were purchased from Sigma.
The Dual-Luciferase Assay (DLR) kit, pRL-CMV luciferase constitutive reporter
plasmid, pRL-SV40 luciferase constitutive reporter plasmid, and pRL-TK luciferase
constitutive reporter plasmid were purchased from Promega. Metafectene transfection
reagent was purchased from Biontex (Martinsried/Planegg, Germany). The EPOHypoxia Response Element (HRE)-luciferase reporter plasmid, with four copies of the
HRE consensus sequence from the promoter of the erythropoietin gene in the pGL3
vector was a kind gift of Dr. Florent Soubrier, INSERM, Paris, France. The PGK-1-HRE
luciferase reporter plasmid, which contains six copies of a 24 base pair sequence
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including the HRE sequence from the phosphoglycerate kinase-1 (PGK-1) promoter
upstream of the TK luciferase promoter in the pGL3 vector, was a kind gift of Dr. Peter
Ratcliffe, University of Oxford, England. The pc3DNA HIF-1α 3xSDM construct was a
kind gift of Dr. Christine Warnecke, University Erlangen-Nuremberg, Erlangen,
Germany. The Rcho-1 trophoblast cell line was a kind gift of Dr. Michael Soares, Kansas
University Medical Center, Kansas City, Kansas. The mouse monoclonal pan-actin
antibody was a kind gift of Dr. James Lessard, Cincinnati Children’s Research
Foundation, Cincinnati, Ohio. The Cos 7 and NIH-3T3 cell lines were obtained from
ATCC.

B. Cell culture:
1. Rcho-1 Trophoblasts
i. Normal Stem Cell Culture
The Rcho-1 placental trophoblast cell line was cultured as previously described
[6, 22, 26]. Briefly, proliferative stem cells were passaged at subconfluence in CM20
media (RPMI, 20% FBS, 50uM 2-mercaptoethanol, 1mM sodium pyruvate solution,
20mM HEPES buffer, 1% antibiotic-antimycotic). Cells were not cultured higher than
passage 25, to prevent any accumulated mutations from affecting results. Cell number
and viability were determined by Trypan Blue exclusion.
ii. Differentiation
Rcho-1 trophoblasts were differentiated by serum replacement as previously
described [6, 22, 26]. Briefly, Rcho-1 cells were plated and allowed to proliferate for
three days in CM20 media at 21% O2 and 37 C. Differentiation media (NCTC-135
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medium (Sigma), 50uM 2-mercaptoethanol, 1mM sodium pyruvate, 10% horse serum,
and antibiotic) was applied to cells on the third day (day 0) following plating. Media was
changed on days 1, 3, and 5, with collection, fixing, or analysis of cells on day 7. For
cells differentiated in hypoxia, media was allowed to equilibrate inside the hypoxia
chamber at least thirty minutes prior to application to minimize oxygen variation. Cells
maintained in CM20 media run concurrently as a control.
iii. Hypoxic Incubation
For hypoxic incubation, cells were plated and allowed to settle in normoxia (21%
O2) overnight or for 7 days, as noted. Cells were then transferred to a Coy hypoxia
chamber (Coy Laboratories, Grass Lake, Michigan) for incubation at the desired oxygen
tension. The chamber was maintained at 37 °C. For nuclear extracts, cells in hypoxia
were collected from the plate while inside the chamber. All reagents were allowed to
equilibrate for thirty minutes prior to use on cells within the hypoxia chamber to
minimize oxygen exposure. For luciferase assays, cells in hypoxia were removed from
the chamber and immediately processed with lysis buffer.

2. Other cell lines
Cos 7 and NIH-3T3 cells were cultured in DMEM, 10% FBS, and 1% antibioticantimycotic.
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C. Cell Collection
1. Whole Cell Lysates
Whole cell lysates of Cos 7 cells were collected in Buffer D (20mM Tris pH 7.5,
1% NP40, 10% glycerol, 0.2mM 0.5M EDTA pH 8.0) plus protease inhibitor cocktail,
sonicated, and centrifuged 15 minutes at 14,500 rpm. Rcho-1 lysates were collected in
Buffer D plus protease inhibitor cocktail and proteasome inhibitor. Lysates were
sonicated and centrifuged 15 minutes at 14,500 rpm. Protein concentration was
determined using Bradford reagent [74]. Lysates were stored at -80 C until use.

2. Nuclear Extraction
Nuclear extracts were collected using the NXTRACT CelLytic™ NuCLEAR™
Extraction Kit per the manufacturer’s instructions. Briefly, cells were washed in 1x PBS
three times and then gently scraped off the plate in 1xPBS with a rubber spatula. Cells
were spun down at 450 x g for five minutes at 4 C and the supernatant was removed.
Packed cell volume (PCV) was estimated and three times that volume of 1x hypotonic
lysis buffer plus DTT and protease inhibitor cocktail was used to resuspend the cells.
Resuspension was incubated on ice 15 minutes. 10% IGEPAL CA-360 detergent (nonionic NP-40) was added to a final concentration of 6% and cells vortexed vigorously for
10 seconds to lyse outer membrane. Cells were centifuged immediately for 30 seconds at
4° C and the cytoplasmic supernatant was removed to a fresh tube. The remaining pellet
was resuspended in 2/3 the PCV Extraction Buffer plus DTT and protease inhibitor
cocktail. The resuspension was vortexed on high speed for 30 minutes at 4° C then
centrifuged 5 minutes. Nuclear supernatant was transferred to clean, chilled tube.

29

Nuclear and cytoplasmic fraction protein concentrations were determined using Bradford
reagent and stored at -80 C until use [74].

D. Western Blot Analysis
50 µg of protein was heated with Reducing Sample Buffer (15.62 mM Tris, 0.5%
SDS, 3.125 % glycerol, 0.625% β-mercaptoethanol, and 0.025% Bromophenol Blue) at
95 °C for 10 minutes, then loaded on an 8% polyacrylamide gel and separated by SDSPAGE electrophoresis. Proteins were transferred to polyvinylidene fluoride (PVDF)
membrane in transfer buffer (25 mM Tris, 192 mM Glycine, and 20% methanol)
overnight at 100 mAmp constant voltage; the membrane was stained with Ponceau Red
stain to confirm transfer and incubated with blocking buffer (60 mM Tris base, 204 mM
NaCl, 5% non-fat milk, and 0.05% Tween-20, pH 7.4) for 2 hours at room temperature
[6, 22]. The blot was probed for either HIF-1α, with a rabbit polyclonal primary
antibody, or HIF-2α, with a mouse monoclonal or rabbit polyclonal antibody (1:1,000;
overnight at 4 °C) and then an HRP-conjugated anti-rabbit or anti- mouse secondary
(1:50,000; 45 minutes at room temperature). Where indicated, the blot was also probed
for actin to confirm equal loading using a mouse monoclonal antibody against pan-actin
(1:4,000; overnight at 4 °C) and an HRP-conjugated anti-mouse secondary as described.
Proteins were visualized using chemiluminescence and Kodak X-ray film (XAR-5).
The blots were stripped of antibody for reprobing using stripping buffer (25mM
glycine-HCL and 1% SDS, pH 2.0). The membrane was covered with stripping buffer
and incubated at 56° C for 45 minutes. The blot was rinsed and reblocked in blocking
buffer for 60 minutes, then incubated with the appropriate secondary antibody (1:50,000)
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for 60 minutes at room temperature. Chemiluminescence was applied and the stripped
blot was exposed to film to ensure that all antibodies had been removed. After a
thorough rinsing in 1xPBS-T, the blot was reincubated with primary antibody as
described above.
Densitometric analysis of Western blots was performed using ImageJ software as
previously described [75-76].

E. Conventional Luciferase Assay
Conventional luciferase assays were performed as illustrated (Figure 7A). Rcho-1
cells (2x105 cells/ml) were transfected with 5 μl Metafectene, 1 μg EPO-HRE reporter or
1 μg PGK-1-HRE plasmid and 0.2 μg constitutive reporter plasmid, for 18 hours. The
DNA plasmid and Metafectene were allowed to complex at room temperature for 20
minutes in serum-free, antibiotic-free media before application to cells [77].
Twenty-four hours post-transfection, one set of samples was moved to a Coy
hypoxia chamber (Coy Laboratories, Grass Lake, Michigan) set at 3%, 5%, or 8% O2
with 5% CO2/ N2 balance while the parallel set was maintained at 21% O2/ 5% CO2
(normoxia). Cells were collected, analyzed and luciferase reporter activity was
determined using the Dual-Luciferase Reporter Assay System (Promega) according to the
manufacturer’s instructions and measured using a Dynex Revelation 4.06 luminometer
(Dynex Technologies, Chantilly, Virginia) [77]. For analysis, the experimental reporter
was normalized to the constitutive reporter to control for differences in transfection
efficiency. Luciferase activity from hypoxic samples was then compared to the luciferase
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Figure 7: Luciferase reporter assays using conventional transfection protocol and
equal density passaging of single transfections.
A) In the conventional luciferase assay, two or more plates are plated with equal
cell number and individually transfected with identical experimental and constitutive
luciferase reporter constructs. During analysis, differences in initial transfection
efficiency are accounted for by normalizing the luminescence obtained for the
experimental reporter to the luminescence obtained for the constitutive reporter. B) In
the split transfection assay, one plate of cells is transfected. That plate is then split
equally to two or more plates. However, the luminescence obtained for the experimental
reporter can be analyzed without normalizing as equal transfection efficiency between
plates is ensured by splitting the original transfection equally prior to treatment.
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activity in the normoxic sample to determine a fold-change in reporter induction in
hypoxia.

F. Split Transfection Luciferase Assay
Split transfections were performed as illustrated (Figure 7B). For hypoxic experiments,
one plate of Rcho-1, Cos 7, or NIH-3T3 cells (1x105 cells/ml) was transfected with 5 µl
Metafectene, 1 µg EPO-HRE or 1 µg PGK-1-HRE reporter and 0.2 µg of either pRLCMV luciferase constitutive reporter, pRL-SV40 luciferase constitutive reporter, or pRLTK luciferase constitutive reporter. DNA and Metafectene were mixed and incubated at
room temperature for 20 minutes in serum-free, antibiotic-free media then applied to cells
for 18 hours at 37 C/ 5% CO2.
Twenty-four hours post-transfection, the cells were trypsinized and split equally,
as determined by cell number, into two sets of 60mm tissue culture dishes. 24 hours
later, one set of plates from each constitutive reporter was moved to the Coy hypoxia
chamber, set at 5% O2, for 18 hours while the other set was maintained at 21% O2. The
cells were then washed in cold 1xPBS and incubated in 500ul 1xPassive Lysis Buffer for
15 minutes. The cells were removed from the plate with a rubber spatula and centrifuged
for 7 minutes at 11,000 rpm to remove debris. Supernatants were used for further
analysis. Luciferase reporter activity was determined using the Dual-Luciferase Reporter
Assay System and measured on a Dynex Revelation 4.06 luminometer (Dynex
Technologies, Chantilly, Virginia). For split-transfections, where transfection efficiency
is the same in all samples, the induction of the reporter of interest was directly compared
to the induction of the same reporter in the normoxic control.
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To examine the effect of artificially-induced HIF stabilization, one plate of Rcho1 cells (1x105 cells/ml) per constitutive reporter was transfected as above. 24 hours posttransfection, the cells were trypsinized and split equally by volume into three sets of
60mm tissue culture dishes. Cells transfected with each constitutive reporter were treated
at 21% O2 with either100 µM DFO, 100 µM CoCl2, or vehicle for 18 hours to mimic
hypoxic induction. The cells were processed and analysed for luciferase activity as
described earlier.

G. Sequence Analysis
Sequence analysis was performed using PATCH promoter analysis Public
Version 1.0 with boundary set at 87.5 [78].

H. Statistics
Standard deviation and statistical significance were calculated using a two-tailed
Student T-test. Significance was set at p < 0.05. All experiments were independently
repeated a minimum of three times.
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RESULTS
A. HIF-2α
1. HIF-2α protein is not detectable in Rcho-1 trophoblast cells.
Preliminary RT-PCR studies have indicated that HIF-2α mRNA was present in
Rcho-1 trophoblasts maintained in the stem state at all levels of oxygen tension (data not
shown). However, to date, expression of HIF-2α protein in Rcho-1 trophoblasts has not
been reported. To determine if HIF-2α protein expression correlates with the mRNA
production, Rcho-1 trophoblasts were plated at 3.1 x 105 cells per plate. On day 0, two
plates were transferred to the hypoxia chamber set at 3%, 5%, or 8% O2. Two plates
were maintained at 21% O2. One plate in hypoxia and one plate at normoxia were
differentiated, beginning on day 0 and continuing through collection, as described in
Materials and Methods. Nuclear extracts were collected on day 7 and 50 µg protein was
Western blotted and transferred to PVDF membrane as described in Materials and
Methods. Fifty micrograms of whole cell lysate from Cos 7 cells that had been
transfected with stable constructs of HIF-1α and HIF-2α, which both have three site
directed amino acid mutations, were also run as controls. The blot was incubated with a
mouse monoclonal primary antibody to HIF-2α and the HRP-conjugated anti-mouse
secondary antibody. Proteins were visualized and captured on film. All experiments
were performed independently in triplicate to confirm results.
Protein appears on the blot in Rcho-1 trophoblast nuclear extract lanes at about
150 kDa, at 66 kDa, and at 35 kDa, with a doublet appearing at about 60 kDa, in all lanes,
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regardless of oxygen tension at the time of culture. The protein at 35 kDa was used as a
fortuitous internal loading control, as it also appeared in the Cos 7 control lanes. Also in
the Cos 7 lanes, protein was observed at 66 kDa in both HIF-1α SDM and HIF-2α
3xSDM transfected lanes. Protein was also observed at 120 kDa in the Cos 7 cells
transfected with HIF-2α 3xSDM that was absent in their HIF-1α 3xSDM transfected
counterparts (Figure 8).
In an attempt to elucidate the cause of the higher molecular weight of HIF-2α
seen in Rcho-1 cells, Rcho-1 stem cells were either mock-transfected or transfected three
times with wild type, flag-tagged HIF-2α or pc3HIF-2α 3xSDM constructs in order to
determine if the higher molecular weight observed in Rcho-1 cells was due to unique
modifications of the HIF-2 protein in those cells. Rcho-1 stem cells were also treated
with 100uM CoCl2, a hypoxia mimetic, for 18 hours. Nuclear extracts were collected and
proteins were separated by SDS-PAGE as described. Whole cell lysates from Cos 7 cells
transfected with the HIF-2α overexpression construct were again used as a control. The
blot was probed for HIF-2α using the same mouse monoclonal antibody previously used.
Protein again appeared in all Rcho-1 lanes at 150 kDa that was not present in Cos 7
control lanes. Additional protein appeared at 120 kDa in lanes from Rcho-1 stem cells
transfected with the HIF-2α plasmids and in the Cos 7 control lane (Figure 9). Though
protein did appear at 120 kDa in Rcho-1 lanes, it did not resolve the issue of the protein
observed at the higher molecular weight.
In a final attempt to clarify the HIF-2α protein reactivity observed at 150 kDa,
Rcho-1 cells were maintained as stem or differentiated for seven days at the indicated
oxygen level. Nuclear extracts were collected and 50 µg of protein was Western blotted
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Figure 8: HIF-2α protein levels in stem and differentiated Rcho-1 trophoblasts.
A) Rcho-1 trophoblasts were cultured in the stem-cell state or differentiated at
the indicated oxygen level for 7 days as described in Materials and Methods. Nuclear
extracts were collected as described. Cos 7 cells were transfected with either pc3HIF-1α
3xSDM or pc3HIF-2α 3xSDM and whole cell lysates were collected. Proteins were
separated by SDS-PAGE then transferred to PVDF membrane. The blot was probed with
a mouse monoclonal antibody against HIF-2α (NB100-132) as described in Materials and
Methods. B) Densitometric analysis of HIF-2α protein levels relative the amount of the
internal loading control. Values are normalized to 21% O2, represented as 1.
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Figure 9: HIF-2α is not post-transcriptionally modified in Rcho-1 cells.
Rcho-1 trophoblasts were plated and either mock transfected or transfected with a
wild-type flag-tagged HIF-2α construct or pc3HIF-2α 3xSDM construct as described in
Materials and Methods. Rcho-1 trophoblasts were also plated and treated with 100 µM
CoCl2 for 18 hours. Nuclear extracts were collected as described. Cos 7 cells were
transfected with pc3HIF-2α 3xSDM and whole cell lysates were collected. Proteins were
separated by SDS-PAGE then transferred to PVDF membrane. The blot was probed with
a mouse monoclonal antibody against HIF-2α (NB100-132) as described in Materials and
Methods.
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and transferred as described. Whole cell lysates of Cos 7 cells overexpressing the
pc3HIF-1α 3xSDM or pc3HIF-2α 3xSDM plasmid were run as positive controls.
Nuclear extracts of Rcho-1 trophoblasts transfected with pc3HIF-1α 3xSDM or pc3HIF2α 3xSDM or treated with 100 µM CoCl2 were also run as controls.
Because the availability of good HIF-2α antibodies is limited, and the antibodies
that are available vary in reliability, the blot was probed for HIF-2α using a rabbit
polyclonal antibody that reportedly yielded better results than the mouse monoclonal
antibody used previously. No protein appeared in any lane at 150 kDa, as seen
previously. Protein also did not appear at 120 kDa in any lane with Rcho-1s cultured at
any percent of oxygen, or in the lane with CoCl2 treated Rcho-1 stem cells. However,
HIF-2α protein was observed at the expected 120 kDa in both lanes where cells had been
transfected with the HIF-2α over-expression construct. Additionally, no cross reactive
bands were present at lower molecular weights in any lane, in contrast to earlier results.
The blot was also incubated with a mouse monoclonal pan-actin antibody to confirm
equal loading (Figure 10, top and bottom).
Due to the absence of HIF-2α protein in any lane with treated samples, the results
needed to be confirmed. To do this, the blot was stripped as described in Materials and
Methods and reprobed for HIF-1α using a polyclonal antibody that had been shown to be
reliable. Protein appeared at 120 kDa in all treatment lanes, with higher intensity bands
at lower levels of oxygen and in CoCl2 treated cells. Additionally, protein appeared at
120 kDa in lanes with Cos 7 and Rcho-1 cells transfected with HIF-1α over-expression,
but not HIF-2α over-expression, constructs (Figure 10, middle).
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Figure 10: HIF-1α but not HIF-2α protein is present in Rcho-1 trophoblasts
A) Rcho-1 trophoblasts were cultured in the stem-cell state or differentiated at the
indicated oxygen level for 7 days as described in Materials and Methods. Rcho-1
trophoblast stem cells were also transfected three times with either pc3HIF-1α 3xSDM or
pc3HIF-2α 3xSDM as described. Nuclear extracts were collected as described. Cos 7
cells were transfected with either pc3HIF-1α 3xSDM or pc3HIF-2α 3xSDM and whole
cell lysates were collected. Proteins were separated by SDS-PAGE then transferred to
PVDF membrane as described. Membrane was probed with a rabbit polyclonal antibody
against HIF-2α and then with a mouse monoclonal antibody against pan-actin. The blot
was then stripped as described and reprobed with a rabbit polyclonal antibody against
HIF-1α as described in Materials and Methods. B) Densitometric analysis of HIF-2α
and HIF-1α protein levels relative the amount of the actin. Values are normalized to the
appropriate 21% O2 control, represented as 1.
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2. HIF-2α transcriptional activity in Rcho-1 trophoblasts cannot be determined using
the EPO-HRE luciferase reporter.
The luciferase dual-reporter assay was used to determine the transcriptional
activity of HIF-2α in Rcho-1 trophoblasts in an attempt to confirm the results of the
western blots. The EPO-HRE luciferase experimental reporter was used as it has been
shown to be preferential for HIF-2 binding [28-29]. Using the split transfection
luciferase assay, Rcho-1 cells were plated at 1.0 X 105 cells and transfected as described
in Materials and Methods with 1 µg of EPO-HRE luciferase experimental (firefly)
reporter plasmid and 0.2 µg of pRL-SV40 luciferase constitutive (Renilla) reporter
plasmid. The transfection was applied overnight, after which cells were given a twentyfour hour recovery period. The plate of transfected cells was then split equally by cell
number to two plates. Twenty-four hours later, one plate was moved to the indicated
level of hypoxia for 18 hours while the other plate was maintained at 21% O2 as a
control. Cells were lysed, collected, and analyzed as described in Materials and Methods.
The results were normalized using the traditional luciferase assay method to ensure that
transfection efficiency was equal between samples. In this method, the data for the
experimental reporter is normalized to the data for the constitutive reporter before it is
compared to other samples. There was no significant induction of the EPO-HRE
luciferase reporter at any level of hypoxia in Rcho-1 trophoblasts when the conventional
method of normalizing transfection efficiency was used (Figure 11A). The induction of
the HIF-1 specific luciferase reporter, PGK-1-HRE, was also examined using the
protocol described above. Surprisingly, there was no significant induction of the PGK-1HRE luciferase reporter when the conventional luciferase assay was used, even though
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Figure 11: Fold induction of EPO-HRE and PGK-1 HRE luciferase reporters using
the conventional luciferase assay normalizing method.
Rcho-1s were plated at a density of 1.0 x 105 cells and incubated 24 hours, then
transfected with EPO-HRE and pRL-SV40 luciferase reporters as described in Materials
and Methods. Samples were treated at the O2 concentration indicated and analyzed as
described in Materials and Methods. Results are average of three independent
experiments, normalized to values obtained for 21% O2, represented as 1. Error bars
represent standard deviation, * p ≤ 0.05. A) Induction of EPO-HRE luciferase reporter
was normalized to induction of pRL-SV40 luciferase constitutive reporter, per
conventional luciferase assay protocol. B) Induction of PGK-1-HRE luciferase reporter
was normalized to induction of pRL-SV40 luciferase constitutive reporter, per
conventional luciferase assay protocol.
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PGK-1 is a direct HIF-1 target (Figure 11B) [29, 31, 33].
However, because the split transfection assay was used, it was possible to directly
compare the induction of the experimental reporters at various levels of hypoxia, without
first normalizing them to the luciferase constitutive reporters. The results were examined
using this method to see if they were comparable to the conventional method of
normalizing. Surprisingly, the EPO-HRE luciferase reporter was significantly induced at
all levels of hypoxia in Rcho-1 trophoblasts, despite the absence of HIF-2α protein by
Western Blot and contradicting the results obtained after normalizing with the
constitutive reporter (Figure 12A). As expected, the PGK-1-HRE luciferase reporter was
also significantly induced when split transfection analysis was used (Figure 12B)

B. Luciferase Constitutive Reporters
1. Luciferase constitutive reporters are induced by hypoxia.
Other studies in our laboratory had also examined the transcriptional activity of
HIF-1α in Rcho-1 trophoblast stem cells utilizing the conventional luciferase dualreporter assay. To determine the effects of hypoxia on HIF-1 activity, Rcho-1
trophoblast cells were transfected with either the PGK-1-HRE or EPO-HRE experimental
luciferase reporter plasmid, which contains the firefly luciferase gene under the control of
six copies of the consensus HRE sequence from PGK-1 or four copies of the consensus
HRE sequence from EPO, respectively, and the pRL-SV40 constitutive luciferase
reporter. Both PGK-1 and EPO have been shown to be direct targets of HIF-1 [5-6, 29,
36, 43, 50, 57-60]. The transfected cells were then exposed to varying levels of hypoxia
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Figure 12: Fold induction of EPO-HRE and PGK-1 HRE luciferase reporters using
the split transfection luciferase assay normalizing method.
Rcho-1s were plated at a density of 1.0 x 105 cells and incubated 24 hours, then
transfected with EPO-HRE and pRL-SV40 luciferase reporters as described in Materials
and Methods. Samples were treated at the O2 concentration indicated and analyzed as
described in Materials and Methods. Results are average of three independent
experiments, normalized to values obtained for 21% O2, represented as 1. Error bars
represent standard deviation, * p ≤ 0.05. A) Induction of EPO-HRE luciferase reporter
by hypoxia, using the split transfection assay protocol. B) Induction of PGK-1-HRE
luciferase reporter by hypoxia, using the split transfection assay protocol.
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(3-8% O2) or normoxia (21% O2) and the amount of luciferase was quantified by
conventional luciferase assay to determine changes in HIF-1 activity.
We observed that the level of fluorescence recorded for the pRL-SV40
constitutive reporter alone was significantly higher in hypoxic samples compared to the
constitutive reporter in normoxic controls (Figure 13). Maximal induction occurred with
exposure to 5% O2, with a 9-fold induction of the pRL-SV40 constitutive reporter. A 5fold induction of the pRL-SV40 constitutive reporter was observed at 8% O2 and, a 3fold induction of the reporter was seen at 3% O2, indicating that the level of pRL-SV40
constitutive reporter induction in hypoxia was highly variable. Because the pRL-SV40
constitutive reporter is used to normalize for transfection efficiency between samples,
high levels of variability introduce an increase in potential errors within our data analysis.
In order to minimize potential variability in our data collection, we instituted an
alternate transfection protocol that normalizes transfection efficiency between samples
prior to treatment. This method allows experimental (firefly) reporter induction to be
directly compared between samples without needing a constitutive (Renilla) reporter to
normalize for transfection efficiency (Figure 7B).
In light of the high degree of variability, the pRL-SV40 luciferase constitutive
reporter data that had been used to normalize the EPO-HRE luciferase data in the HIF-2α
study was examined. Because the split transfection assay was used, the amount of
constitutive reporter activity should be equal. However, in comparison to constitutive
reporter activity at 21% O2, set as 1, the pRL-SV40 luciferase constitutive reporter was
significantly induced by all levels of hypoxia (Figure 14).
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Figure 13: Fold increase in pRL-SV40 luciferase constitutive reporter activity in
Rcho-1 trophoblast cells in hypoxia.
Parallel plates of Rcho-1 trophoblast cells were plated at equal cell number of 1.0
x 105 cells and transfected with 1 µg EPO-HRE and 0.2 µg pRL-SV40, using the
conventional luciferase assay. Samples were treated at the O2 concentration indicated and
analyzed as described in Materials and Methods. Results are the average of three
independent experiments, normalized to values obtained for 21% O2, represented as 1.
Error bars represent standard deviation, * p ≤ 0.05.
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Figure 14: Fold induction of pRL-SV40 luciferase constitutive reporter after
exposure to hypoxia, using the split transfection method.
The split transfection method was used. Rcho-1s were plated at a density of 1.0 x
105 cells and incubated 24 hours, then transfected with EPO-HRE and pRL-SV40
luciferase reporters as described in Materials and Methods. Samples were treated at the
O2 concentration indicated and analyzed as described in Materials and Methods.
Induction of pRL-SV40 luciferase constitutive reporter alone, after exposure to hypoxia
is shown. Results are an average of three independent experiments, normalized to values
obtained for 21% O2, represented as 1. Error bars represent standard deviation, * p ≤
0.05.
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To determine if this hypoxic induction was limited to pRL-SV40, we repeated the
split transfection assay with two other commonly used commercially available
constitutive luciferase reporters, pRL-CMV and pRL-TK. Our results indicate that pRLCMV is also significantly induced by hypoxia (~ 3-fold). Plasmid RL-TK induction by
hypoxia did not reach statistical significance (Figure 15A). Similar, but not identical,
results were obtained when the PGK-HRE experimental reporter was used, with
significant hypoxic induction of both pRL-CMV and pRL-TK constitutive luciferase
reporters, indicating that the hypoxic induction was most likely independent of the
experimental reporter (Figure 15B).
2. Hypoxic induction of luciferase constitutive reporters is not species or celltype specific.

Rcho-1 trophoblasts are a rodent, choriocarcinoma-derived placental stem cell
line that serves as a model of the giant cell placental lineage [6, 22, 26]. To determine if
the induction of constitutive luciferase reporters by hypoxia was restricted to the
placental cell type, the split transfection assays were repeated in Cos-7 cells, an
immortalized, SV40-transformed African green monkey kidney cell line [79], and NIH3T3 cells, a primary mouse embryonic fibroblast cell [80]. The EPO-HRE experimental
luciferase reporter was co-transfected with the pRL-SV40, pRL-CMV, or pRL-TK
constitutive luciferase reporters. In Cos 7 cells, both pRL-SV40 and pRL-CMV were
significantly induced (1.5-fold and 3.25-fold, respectively) by exposure to hypoxia of 5%
O2 (Figure 16). As in Rcho-1 trophoblasts, pRL-TK was induced by exposure to
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Figure 15: Induction of luciferase constitutive reporters by hypoxia in Rcho-1
trophoblasts with EPO-HRE and PGK-1-HRE reporters.
The split transfection method was used. Equal numbers of Rcho-1 cells were
plated and incubated 24 hours. Cells were transfected with A) 1 µg EPO-HRE luciferase
reporter and 0.2 µg pRL-SV40, pRL-CMV, or pRL-TK constitutive luciferase reporter
or B) 1 µg PGK-1-HRE luciferase reporter and 0.2 µg pRL-SV40, pRL-CMV, or pRLTK constitutive luciferase reporter as described in Materials and Methods. Samples were
treated at the O2 concentration indicated and analyzed as described in Materials and
Methods. Results are average of three independent experiments, normalized to values
obtained for 21% O2, represented as 1. Error bars represent standard deviation,
* p ≤ 0.05.
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Figure 16: Induction of luciferase constitutive reporters by hypoxia in Cos 7 cells.
The split transfection method was used. Twenty-four hours after plating, Cos 7
cells were transfected with 1 µg EPO-HRE luciferase reporter and 0.2 µg pRL-CMV,
pRL-SV40, or pRL-TK constitutive luciferase reporter as described in Materials and
Methods. Samples were treated at the O2 concentration indicated and analyzed as
described in Materials and Methods. Results are average of three independent
experiments, normalized to values obtained for 21% O2, represented as 1. Error bars
represent standard deviation, * p ≤0.05.
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hypoxia, but not to the level of statistical significance. In NIH-3T3 cells, pRL-CMV
showed a significant, nearly 3-fold induction upon exposure to hypoxia of 5% O2, while
pRL-SV40 and pRL-TK had only a slight induction that was not statistically significant
(Figure 17).
3. Hypoxic mimetics do not induce luciferase constitutive reporters.
To evaluate whether consensus HRE or HRE-like sequences played a role in the
hypoxic induction of the constitutive luciferase reporters, we next examined the induction
of constitutive luciferase reporters after treatment with compounds, such as DFO and
CoCl2, that act to stabilize HIF-1α in vitro and allowing transcriptional activation of HIF1 [32, 37, 43, 46, 52, 57-60]. Both compounds act by blocking the action of the prolyl
hydroxylases which target HIF-α for degradation by hydroxylating conserved proline
residues. DFO, an iron chelator, scavenges Fe(II), depleting it as a cofactor. CoCl2 acts
by allowing substitution of Co(II) for Fe(II) as a cofactor of prolyl hydroxylase,
preventing its action [1, 34, 45, 49]. These two compounds were used to evaluate the role
of HIF in the induction of the constitutive luciferase reporters in Rcho-1 trophoblasts
using the split transfection assay. If the binding of consensus HRE or HRE-like
sequences by HIF-1 is responsible for the hypoxic induction of the constitutive luciferase
reporters, stabilization of HIF-1α by DFO or CoCl2 would be predicted to cause an
increase in the level of constitutive reporter luciferase compared to vehicle-treated
samples. Surprisingly, no significant induction of the constitutive luciferase reporters
was observed when luciferase transfected Rcho-1 trophoblast cells were treated with the
hypoxia mimetics DFO and CoCl2 compared to vehicle-treated cells (Figure 18A),
despite the induction of PGK-1-HRE, HIF-1α specific, luciferase reporter in cells treated
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Figure 17: Induction of luciferase constitutive reporters by hypoxia in NIH-3T3
cells.
The spilt transfection method was used. Twenty-four hours after plating, NIH-3T3
fibroblasts were transfected with 1 µg EPO-HRE luciferase reporter and 0.2 µg pRLCMV, pRL-SV40, or pRL-TK constitutive luciferase reporter as described in Materials
and Methods. Samples were treated at the O2 concentration indicated and analyzed as
described in Materials and Methods. Results are average of three independent
experiments, normalized to values obtained for 21% O2, represented as 1. Error bars
represent standard deviation, * p ≤0.05.
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Figure 18: Induction of PGK-1-HRE and luciferase constitutive reporters by DFO
or CoCl2.
The split transfection method was used. Equal numbers of Rcho-1 trophoblasts
were seeded and incubated 24 hours. Rcho-1 trophoblasts were then transfected with A)
1 µg EPO-HRE luciferase reporter and 0.2 µg pRL-CMV, pRL-SV40, or pRL-TK
constitutive luciferase reporter or B) 1 µg PGK-1-HRE luciferase reporter as described in
Materials and Methods. Twenty-four hours post transfection, each plate was split equally
to three plates. Twenty-four hours later one plate from each reporter set was treated with
either 100uM DFO, 100uM CoCl2, or vehicle for 18 hours. Samples were lysed,
collected, and analyzed as described in Materials and Methods. Results are an average of
A) three independent experiments, or B) eight independent experiments, normalized to
values obtained for 21% O2, represented as 1. Error bars represent standard deviation,
* p ≤0.05.
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with DFO and CoCl2 (Figure 18B). HIF-1α protein was also shown to be stabilized by
DFO and CoCl2, indicating that the two compounds were functional (Figure 19).

4. Transfection of HIF-1α does not induce luciferase constitutive reporters.
HIF-1α is stabilized under low oxygen conditions and studies have shown that
protein levels increase when trophoblasts are exposed to hypoxia [4, 29-30, 43]. The
mechanism of stabilization of HIF-1α by hypoxia differs from the stabilization with
hypoxia mimetics such as DFO and CoCl2. Therefore, we examined the induction of
luciferase constitutive reporters after transfecting Rcho-1 cells with a constitutivelyactive, site-directed mutant HIF-1α construct (pc3HIF-1α 3xSDM) that is stable under
normoxic conditions [29]. The pc3HIF-1α 3xSDM construct is stably expressed and
active in normoxia due to two site directed point mutations within the oxygen dependent
degradation domain and one site directed point mutation within the transactivation
domain at the sites of hydroxylation responsible for its usually rapid normoxic turnover
[29].
Rcho-1 trophoblasts were transfected with the EPO-HRE or PGK-1-HRE
luciferase reporter along with one of the three constitutive luciferase reporters and then
plated at equal cell number into four parallel samples, using the split transfection method.
One plate was mock-transfected while the other three were transfected with either
pc3DNA, pEGFP, or pc3HIF-1α 3xSDM. If HIF-1 plays a role in the induction of
constitutive luciferase reporters, the induction seen in cells transfected with the stable
construct should be higher than in mock-transfected cells, cells transfected with only the
vector backbone or cells transfected with EGFP. Results, however, indicate that
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Figure 19: Induction of HIF-1α protein by DFO and CoCl2 in luciferase
transfected Rcho-1 trophoblasts.
A) The split transfection method was used. Equal numbers of Rcho-1
trophoblasts were seeded and incubated 24 hours. Rcho-1 trophoblasts were then
transfected with 1 µg PGK-1-HRE luciferase reporter and 0.2 µg pRL-CMV, pRL-SV40,
or pRL-TK constitutive luciferase reporter as described in Materials and Methods.
Twenty-four hours post transfection, each plate was split equally to three plates. Twentyfour hours later one from each reporter set was treated with either 100 µM DFO, 100 µM
CoCl2, or vehicle for 18 hours. Nuclear extracts were collected and proteins separated by
SDS-PAGE before transfer to PVDF membrane as described in Materials and Methods.
Blot probed for HIF-1α and pan-actin as described. Blots shown are representative of
three independent experiments. B) Densitometric analysis of HIF-1α protein levels
relative the amount of the actin loading control. Values are normalized to 21% O2,
represented as 1.
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transfection with the stable HIF-1α 3xSDM construct failed to induce any of the three
constitutive luciferase reporters above levels seen in control transfections (Figure 20A),
even though the pc3HIF-1α 3xSDM construct did induce an increase in PGK-1-HRE
experimental reporter activity above that of mock transfected, vector transfected, or
enhanced GFP transfected cells (Figure 20B). Additionally, the presence of HIF-1α
protein in cells triple-transfected with the constitutively active HIF-1α construct was
detected by Western blot (Figure 20C). These results indicate that the transcriptional
activation of constitutive luciferase reporters in response to hypoxia may be independent
of HIF-1.

5. Luciferase constitutive reporter promoter sequences do not contain
consensus HREs.
The three constitutive luciferase reporters share a common vector backbone (pRL)
but have different functional promoter regions from genes that can be constitutively
activated in most mammalian cells. Because the induction of the luciferase constitutive
reporters after hypoxic exposure varied between reporters and also between cell types
after using the split transfection method, we hypothesized that the sequence or sequences
responsible for the observed induction of the constitutive reporters were within the
promoter sequences and not within the common backbone [70]. The induction of all
three constitutive luciferase reporters occurred after exposure to hypoxia; therefore, we
analyzed the promoter sequences for consensus HREs using PATCH promoter analysis
software [78]. Analysis of the genetic sequences of SV40, CMV, and TK promoters
revealed that there were no "consensus" HRE sequences (5’-T/G ACGTGCGG-3')
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Figure 20: Induction of PGK-1-HRE, luciferase constitutive reporters, and HIF-1α
protein by pc3DNA HIF-1α 3xSDM
The split transfection method was used. Equal numbers of Rcho-1 trophoblasts
were seeded and incubated 24 hours. Rcho-1 trophoblasts were then transfected with A)
1 µg PGK-1-HRE luciferase reporter or B) 1 µg EPO-HRE luciferase reporter and 0.2 µg
pRL-CMV, pRL-SV40, or pRL-TK constitutive luciferase reporter as described in
Materials and Methods. Twenty-four hours post transfection, each plate was split equally
to four plates. Twenty-four hours later one plate from each reporter set were transfected
with either 5 µg pc3DNA, 5 µg pEGFP, 5 µg pc3HIF-1a 3xSDM, or mock transfected
with reagent alone. Samples were lysed, collected, and analyzed as described in
Materials and Methods. Results are an average of A) three independent experiments or B)
six independent experiments, normalized to values obtained for 21% O2, represented as 1.
Error bars represent standard deviation, * p ≤ 0.05. C) The split transfection method was
used. Equal numbers of Rcho-1 trophoblasts were seeded and incubated 24 hours. Rcho1 trophoblasts were then transfected with 1 µg PGK-1-HRE luciferase reporter and 0.2
µg pRL-CMV, pRL-SV40, or pRL-TK constitutive luciferase reporter as described in
Materials and Methods. Twenty-four hours post transfection, each plate was split equally
to four plates. Twenty-four hours later one plate from each reporter set was transfected
with either 5 µg pc3DNA, 5 µg pEGFP, 5 µg pc3HIF-1a 3xSDM, or mock transfected
with reagent alone. Nuclear extracts were collected and proteins separated by SDS-PAGE
before transfer to PVDF membrane as described in Materials and Methods. Blot was
probed for HIF-1α and pan-actin as described. Blots shown are representative of three
independent experiments.
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present in any of the three constitutive luciferase reporters (Table 1). There was one
HIF-1 binding site (5’-TACGTG-3’) present in the TK promoter, but it was not a full
consensus HRE sequence and no such sites were found in the other promoters. Several
other consensus sequences were found, however, in all three reporters, as listed in Table
1.
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Table 1: Consensus Sequences in Luciferase Constitutive Reporters
The promoter regions for each luciferase constitutive reporter were analyzed for
consensus sequences using Patch Promoter Analysis software. Selected consensus
sequences and their prevalence within each promoter are listed. *Steroid hormone
binding factors include RXR, T3R, GR, ER-α and –β, PPAR-γ, FXR, and LXR.
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Binding Factor
HIF-1
AhR/ARNT
NF-kB
AP-2
CREB
Steroid Hormones*
RXR
PPAR-γ
LXR
T3R
GR
ER

Consensus Sequence
5’-TACGTG-3’
5’-T/GNGCGTGA/CG/CA-3’
5'-GGGACTTTCC-3'
5'-CCCAGGC-3'
5'-TGACGTCA-3'
5'-GGGGTCA-3'
5'-AGGTCAnAGGTCA-3'
5'-AGGTCAnnnnAGGTCA-3'
5'-TA/GAGGTCA-3'
5'-GGTACAnnnTGTTCT-3'
5'-GGTCAnnnACTGG-3'
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DISCUSSION
A. HIF-2α
1. HIF-2α protein is not detectable in Rcho-1 trophoblasts.
Through these studies, the contribution of HIF-2α in Rcho-1 trophoblasts was
explored and the role of HIF-1α in the hypoxic induction of luciferase constitutive
reporters was investigated. Though preliminary studies in our lab identified HIF-2α
mRNA expression in Rcho-1 trophoblasts at all levels of oxygen, HIF-2α protein was not
detected in nuclear extracts at any level of hypoxia or after treatment with CoCl2, despite
high levels of HIF-1α expression. Initially, Western blots indicated that HIF-2α protein
levels appeared to correlate with mRNA expression. However, the high molecular
weight (150 kDa compared to120 kDa) of HIF-2α in Rcho-1 trophoblasts was
inconsistent with published results. Rcho-1 stem cells were transfected with a stable
HIF-2α construct or a wild-type HIF-2α construct that was flag-tagged to determine if a
phosphorylation event or other post-translational modification was the cause of the
disparity. Low levels of HIF-2α were seen at the correct molecular weight of 120 kDa in
cells transfected with HIF-2α constructs. The protein observed in the wild-type
transfected cells was most likely caused by overwhelming the degradation pathway with
excess protein. However, the higher molecular weight band was still present in these
transfected cells, so the disparity was not resolved. Finally, a new polyclonal antibody
was used. Surprisingly, no band appeared at the higher molecular weight. HIF-2α was
present in Cos 7 and Rcho-1 cells transfected with the stable HIF-2α construct, but not in
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any other lane. The blot was reprobed for HIF-1α to confirm these results. Strong HIF1α expression was observed at 3% and 5% oxygen and in lanes transfected with stable
HIF-1α constructs or treated with CoCl2, with lower levels of HIF-1α at 8% and 21% O2.
It is likely, therefore, that the band originally presumed to be HIF-2α was, in fact, a
cross-reactive band between the mouse monoclonal antibody and the rodent protein. This
is supported by the absence of the band in Cos 7 (monkey) cells and in Rcho-1 cells when
a rabbit polyclonal antibody is used.
2. Model systems of placental formation
From this study, it was concluded that HIF-2α is not present in Rcho-1 cells or is
present in such low levels that it is undetectable with the available tools. This correlates
with other studies that have found that HIF-2α is not expressed in murine embryonic
stem cells, or that protein is present but not active [3, 33]. High levels of HIF-2α protein
have been found in vascular endothelial cells and from preeclamptic human placentas,
cells which may not have blastocyst origins [5, 8, 20, 30, 33, 35]. The difficulty in
examining and characterizing the development of the human placenta lies in the
limitations of the cell models available for study. Though murine cell models share many
characteristics and have a high degree of homology to their human homologs, there are
aspects of development that differ substantially [11, 16, 18-19]. The expression of
certain hormones and the spatial-temporal timing of cell differentiation between mice and
humans are not conserved and so any findings made using mouse cell lines must be
extrapolated carefully to the actual human process.
An additional difficulty in the study of trophoblast differentiation lies in the cell
lines themselves. Though all three cell lines commonly used in the study of trophoblasts
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have been analyzed and confirmed as being models for their specific lineage, each one
has its own limitations. The TS3.5 cell line differentiates into all murine trophoblast
lineages simultaneously making the study of a specific cell lineage difficult [13, 21-23].
Chemicals can be used to “push” the cells toward one lineage but it is unclear if the
inducing factors are similar in vivo [21-23]. Therefore, these studies must be analyzed
critically to ensure that results are truly a lineage-specific phenomenon and not a product
of the chemical treatment. The SM10 and Rcho-1 trophoblast cell lines have been
shown to be committed to differentiate toward the labyrinthine and giant cell lineages,
respectively, making them a more reliable way to study the functions of a particular
lineage [21, 24, 26].
Placental development occurs with intimate contact between trophoblast stem
cell types and between mother and fetus. Additionally, cells presumably receive many
other signals from their environment that contribute to the spatial-temporal timing of their
differentiation. Therefore, paradoxically, it is difficult to fully elucidate the development,
differentiation, and functions of a particular cell lineage in the absence of those signals.
Cell lines with tumor origins, such as the Rcho-1 cell line, must also be used carefully, as
their derivation may lend them characteristics atypical of the lineage they model. Though
studies show that Rcho-1 trophoblast cells display all the characteristics of the actual
giant cell lineage, care must still be taken when results are interpreted [6, 22]. The final
limitation of using derived cell lines is the conditions under which they are cultured.
Trophoblast stem cells become lineage committed and exist in a hypoxic environment [13, 4-7, 11-13]. The gradient of oxygen experienced by cells as the maternal decidua is
invaded and blood flow established is probably also accompanied by other signals, such
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as location and cell-cell contact, which all serve to regulate differentiate. These in vivo
conditions have yet to be fully elucidated and are difficult to replicate accurately in a cell
culture system. Furthermore, cell lines are often maintained and many studies are
conducted in ambient air (21% O2), which may shift the cell lines away from their typical
in vivo characteristics. Despite these problems, the cell lines used to characterize
trophoblast differentiation are useful tools and have greatly expanded the body of
knowledge concerning placental development and have allowed the molecular
mechanisms behind many processes to be elucidated.

B. Luciferase Constitutive Reporters
1. Luciferase constitutive reporters are induced by hypoxia independent of
luciferase experimental reporters.
The transcriptional activity of HIF-2α was also measured using the luciferase
dual-reporter assay, which is very sensitive to changes in transcriptional activity and is
quantifiable. In the conventional luciferase assay, plates of cells are transfected with
luciferase constructs individually prior to treatment. In order to account for the
differences in transfection efficiency between plates, a luciferase constitutive reporter is
used to normalize for transfection efficiency of each plate. Because previous studies in
our lab had revealed a high level of variability in the constitutive reporter readings after
exposure to hypoxia, we began using the split transfection assay. In this protocol, one
plate of cells is transfected with luciferase reporters and then split to equal cell numbers,
equalizing transfection efficiency between plates. The plates can be treated and
experimental luciferase reporter induction can be analyzed without normalizing with a
constitutive reporter, eliminating a source of potential error.
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Using the split transfection method, Rcho-1 cells were transfected with the EPOHRE luciferase experimental reporter, which has been shown by several groups to be
preferentially targeted by HIF-2α. The pRL-SV40 luciferase constitutive reporter was
co-transfected as an additional control. The transfected cells were split equally and
incubated at various levels of hypoxia. Using the conventional method of normalizing
for transfection efficiency, the results indicated that the EPO-HRE reporter was not
activated at any level of hypoxia, supporting the results obtained by Western blot. The
pRL-SV40 luciferase constitutive reporter data was analyzed for variance as all readings
should be extremely similar when the split transfection assay is used. Surprisingly, pRLSV40 luciferase constitutive reporter was significantly induced at all levels of hypoxia
when compared to the 21% O2 control. Reexamination of the EPO-HRE luciferase
reporter induction using the split transfection method allowing direct comparison
revealed that it was significantly induced at all levels of hypoxia, contradicting the results
of the HIF-2α Western blot. However, it does correlate with the high levels of HIF-1α
protein and indicates that the EPO-HRE luciferase reporter may be preferential for HIF2α but that it can still be targeted by HIF-1α and may not be ideal for use in cells
containing both isoforms.
Two other commonly used luciferase constitutive reporters were also tested
alongside the pRL-SV40 luciferase constitutive reporter with both the EPO-HRE and
PGK-1-HRE luciferase experimental reporters in Rcho-1 trophoblasts at 5% O2 as it
represents moderate hypoxia. The pRL-CMV luciferase constitutive reporter was
significantly induced with both experimental reporters while the pRL-TK constitutive
reporter was induced with both experimental reporters but significantly so only with the
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PGK-1-HRE constitutive reporter. This indicates that the hypoxic induction is not
specific to the pRL-SV40 luciferase constitutive reporter but is common to all three
commonly used reporters. The similar induction of luciferase constitutive reporters seen
with the EPO-HRE and PGK-1-HRE experimental reporters indicates that the hypoxic
induction of the constitutive reporters is independent of the experimental reporter used.
2. Hypoxic induction of luciferase constitutive reporters is not cell-type or
species- specific.
The Rcho-1 cell line is a rodent choriocarcinoma derived cell line [6, 22, 26]. To
determine if the hypoxic induction of the luciferase constitutive reporters was specific to
the Rcho-1 cell line, hypoxic induction of all three reporters was tested in two more cells
lines from different species and with different derivations. The Cos 7 cell line is an
African green monkey kidney cell line which has been immortalized by SV40transformation [79]. In contrast, the NIH-3T3 cell lines are primary mouse fibroblast
cells [80]. Even in these vastly different cell lines, significant induction of the luciferase
constitutive reporters was observed. The pRL-SV40 and pRL-CMV reporters were
significantly induced in the Cos 7 line. Plasmid RL-TK was induced but not to statistical
significance. Only the pRL-CMV reporter was significantly induced in the NIH-3T3 cell
line, though both pRL-SV40 and -TK luciferase constitutive reporters do show induction
but not to statistical significance. These results indicate that the hypoxic induction of
luciferase constitutive reporters is not cell-type dependent or species-specific
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3. Stable HIF-1α protein fails to induce luciferase constitutive reporters.
HIFs are major mediators of gene expression under hypoxic conditions, therefore,
it was possible that the hypoxic induction observed was the result of HIF-1 interactions
with the luciferase constitutive reporters. To test this, two chemical stabilizers of HIF1α, DFO and CoCl2 were applied to Rcho-1 trophoblasts transfected with the luciferase
constitutive reporters and either the EPO-HRE or PGK-1-HRE experimental reporters.
Both mimetics failed to induce significant levels of luciferase constitutive reporter
induction, even though HIF-1α protein was stabilized as determined by Western blot and
levels of HIF-1α specific PGK-1-HRE luciferase experimental reporter, a HIF-1α target,
were induced. Because both DFO and CoCl2 disrupt the prolyl and asparaginyl
hydroxylases responsible for HIF-1α degradation, they have commonly been referred to
as hypoxia mimetics. However, the failure of DFO and CoCl2 to induce luciferase
constitutive reporters challenges that label and suggests that hypoxia produces a much
broader spectrum of cellular changes than just HIF-1 induction.
A similar experiment was performed to confirm the results obtained using
chemical stabilizers of HIF-1α. A HIF-1α construct that has been rendered stable in
normoxia by amino acid substitution at the sites of prolyl and asparaginyl hydroxylation
was transfected into Rcho-1 trophoblasts transfected with the luciferase constitutive
reporters and either the EPO-HRE or PGK-1-HRE experimental reporters. Several other
constructs were used as controls. Transfection of the stable HIF-1α construct failed to
significantly induce luciferase constitutive reporters above mock-transfected, pc3DNA,
or pEGFP-N1 transfected controls. The pc3HIF-1α 3xSDM construct did significantly
induce the PGK-1-HRE experimental reporter and did increase HIF-1α protein levels in
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Rcho-1 trohoblasts as seen by Western blot. These results support those obtained using
chemical stabilizers of HIF-1α and indicate that a different mechanism is responsible for
the induction of luciferase constitutive reporters in hypoxia.
4. Luciferase constitutive reporters contain diverse consensus sequences.
Together, the results obtained using DFO, CoCl2, and the normoxically stable
HIF-1α construct indicate that the hypoxic induction of luciferase constitutive reporters is
not directly associated with HIF-1α. All three luciferase constitutive reporters have
identical backbones and only differ in their respective promoter regions [70].
Additionally, the amount of hypoxic induction varied between the luciferase constitutive
reporters in the same cell type. This suggested that the cause of the induction was a
factor whose binding site is present in varying numbers within the promoter regions of all
three luciferase constitutive reporters. Further, this factor is probably differentially
expressed across cell types, which would account for the variation in hypoxic induction
between the luciferase constitutive reporters in different cell types.
Patch promoter analysis software was used to analyze the promoter regions from
all three luciferase constitutive reporters for consensus sequences. As expected, no
consensus HRE sequences were present in any of the reporters. One partial HIF-1
binding site was found within the pRL-TK reporter, which showed the least amount of
significant induction across all three different cell types tested, supporting the supposition
that hypoxic induction of the luciferase constitutive reporters was independent of HIF-1.
Several consensus ARNT binding sites were found within the pRL-CMV and pRL-TK
reporters [81-82]. None were present in the pRL-SV40 promoter, making it unlikely to
be responsible for the hypoxic induction of the luciferase constitutive reporters.
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Similarly, the consensus cAMP response element binding protein (CREB), which has
been shown to be up-regulated under hypoxic conditions, was only present in the pRLCMV and pRL-TK luciferase constitutive reporters [83-84]. While the high number of
CREB sites found in pRL-CMV may contribute to the high induction seen in that
reporter, it is unlikely the primary cause of hypoxic induction as it is not found in all
three luciferase constitutive reporters.
Three consensus binding sequences were found in all three constitutive reporters:
nuclear factor -κB (NF-κB), AP-2, and a Steroid Hormone Response Element (StRE).
The StRE sites contained binding sites for a wide range of steroid receptors including
retinoic acid receptors (RAR), retinoic x receptors (RXR), and the related heterodimer
partners liver x and farnesoid x receptors (LXR and FXR, respectively). Other steroid
binding sites represented are peroxisome proliferator-activated receptor-γ (PPAR-γ),
thyroid hormone receptor (T3R), estrogen receptor -α and -β (ERα and ERβ), and
glucocorticoid receptor (GR). All of these factors have the potential to be up-regulated
under a hypoxic stimulus and can function independently of HIF-1 [85-106].
NF-κB is a highly-conserved transcription factor found in all cells and active in
many signaling pathways for cell growth and proliferation. It is also responsible for a
number of cellular responses to inflammation or stress, particularly oxidative stress, to
protect cells from apoptosis [85-90]. There were five consensus NF-κB binding sites in
the pRL-SV40 promoter, four in the pRL-CMV promoter, and one in the pRL-TK
promoter, which correlate with the relative induction of each reporter in hypoxia. NF-κB
up-regulation in response to the generation of reactive oxygen species or stress from

83

exposure to hypoxia may be responsible for the induction of the luciferase constitutive
reporters [88-90].
AP-2 is another transcription factor that mediates gene expression during cellular
stress responses [91-93]. It is also required during mammalian development for normal
growth and morphogenesis [93-94]. AP-2 can be induced by retinoic acid, cAMP, and
singlet oxygen [91]. It is involved in the formation of trophectoderm cells and required
for kidney formation, supporting its role in regulating cell proliferation. AP-2 also plays
in a role in the suppression of terminal differentiation of cells during embryonic
development [4, 6, 29, 93]. Three consensus AP-2 binding sites were found in the pRLSV40 and pRL-TK luciferase constitutive reporters and four were found in the pRLCMV reporter, indicating that AP-2 may also be involved in the hypoxic induction of
luciferase constitutive reporters.
The steroid hormone binding site (StRE) provides a promising explanation for the
hypoxic induction of luciferase constitutive reporters. As listed earlier, the array of
hormones that can bind to this site is responsible for the regulation of a number of
different responses and pathways. The retinoic acid receptor family (RAR, RXR, LXR,
FXR) binds retinoids such as vitamin A. Retinoids regulate processes that include cell
growth, differentiation, and development. Upon binding, the retinoic acids act as heteroor homodimeric transcription factors and have been shown to protect cells from
hypoxically associated cell death by inhibiting c-Jun and p38, a MAP kinase [95-97].
Several different retinoid response pathways have been identified; the most common
retinoid signaling pathways are the RXR/RAR and RXR/RXR pathways [99]. LXR and
FXR also heterodimerize with RXR to mediate responses in an organ-specific pattern.
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LXR has no known ligands but mediates responses in the visceral organs while the
ligands for FXR are natural bile acids. FXR mediates responses in the kidney, liver,
adrenal gland, and ilium [98-100]. PPARs are another family of transcription factors
closely related to retinoic acid receptor family. PPARs mediate differentiation and
cellular metabolism; the most commonly expressed isoform is PPAR-γ. PPAR-γ exists in
three isoforms (γ1-γ3) with PPAR-γ1 being most widely expressed. PPARs also dimerize
with RXR to mediate the formation of peroxisomes to rid cells of toxic waste [101-103].
Glucocorticoids play an important role in the cellular stress response and in the
maintenance of homeostasis. Glucocorticoids are secreted by the adrenal glands and bind
to their receptor (GR), which binds to DNA at the GRE to mediate gene transcription
[53]. Glucocorticoids may also work with other transcription factors including HIF-1α
and NF-κB to modulate cellular stress responses, inflammation, and hypoxic gene
expression [53, 104]. Thus, complex interactions with HIF-1α or NF-κB, or other
transcription factors may determine the strength of a GR response to cell signals. These
same mechanisms may play a role in the hypoxic induction of luciferase constitutive
reporters.
The estrogen receptor (ER) is also in the superfamily of transcription factors that
can bind to the StRE; it is activated primarily by estrogen. After ligand binding, the ER
is phosphorylated and changes conformation allowing it to bind to DNA to modulate
gene expression. The ER can also be activated by cAMP, growth factors, hypoxia, and
other steroid hormone receptors, such as T3R, and works with a number of co-factors that
affect its activity [8, 105-106]. These cofactors include CBP, ARNT, and HIF-1α. ERα
has been shown to work with HIF-1 at the VEGF promoter to regulate transcription [8,
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54]. ER-α may also interact with the PI3K/Akt pathway to increase VEGF production
[8, 52, 54].
The three consensus sequences found in the promoter regions of the three
luciferase constitutive reporters all have the potential to be up-regulated during hypoxia.
One or more of these sequences may be responsible for the induction of the luciferase
constitutive reporters in hypoxia. Future studies are needed to determine the cause or
causes of the hypoxic induction of the luciferase constitutive reporters and if any other
experimental treatment has the same effects.
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FUTURE STUDIES
NF-κB and the ER are particularly appealing targets for examination of the
mechanism of luciferase constitutive reporter induction by hypoxia. Exposure to hypoxia
causes the generation of reactive oxygen species and causes the cell considerable stress.
NF-κB up-regulation in hypoxia as part of the cell's survival response would explain the
large induction of luciferase constitutive reporters. Additionally, the number of NF-κB
binding sites in each of the luciferase constitutive reporters is closely correlated to the
level of hypoxic induction observed. Varying levels of NF-κB induction in response to
hypoxia may explain the differences in luciferase constitutive reporter induction seen in
different cell types. All tests should be repeated in a broad range of cell types and using
some of the other constitutive reporters, such as lacz or pEGFP, to identify those most
susceptible to error.
In order to begin to elucidate the contribution of transcription factors other than
HIF-1 in the hypoxic induction of luciferase constitutive reporters, luciferase constitutive
reporter induction would be tested using the split transfection assay and treatment with
exogenous hormones or transcription factors, similar to the tests performed for HIF-1.
Luciferase constitutive reporters would be tested for induction over a vehicle control after
treatment with retinoic acid, to test the retinoic acid receptor family; glucocorticoids, to
test GR; estrogen, to test the ER; and exogenous NF-κB to test for NF-κB induction. NFκB induction of luciferase constitutive reporters can also be tested using an NF-κB
specific inhibitor, such as SN50. If NF-κB is responsible for the hypoxic induction of the
87

luciferase constitutive reporters, then treatment with the inhibitor would abolish the
induction of the luciferase constitutive reporters when cells are exposed to hypoxia.
Deletional analysis studies can also be used to determine the cause of hypoxic
induction of the luciferase constitutive reporters. Once the induction of the luciferase
constitutive reporters is ablated through deletion the deleted sequences for each reporter
can be analyzed for consensus sequences. The deleted sequences for each luciferase
constitutive reporter can also be compared to determine if the same factor is responsible
for the hypoxic induction of all three luciferase constitutive reporters.
It is possible that no one factor is responsible for the hypoxic induction of
luciferase constitutive reporters. If, however, a factor is identified, deletional analysis
may identify the exact location of the responsible binding site and its potential for
modification to a non-reactive site. Elucidating the mechanism behind the hypoxic
induction will aid scientists who utilize luciferase assays in the design and interpretation
of experiments and may lead to better, more reliable constructs for use in future
experiments.
The absence of HIF-2α in Rcho-1 trophoblasts also requires much more study. It
would be interesting to reexamine the transcriptional activity of HIF-2 in Rcho-1
trophoblasts using a HIF-2 specific reporter such as OCT4 or others that may be
identified in the future [107]. It would also be interesting to silence HIF-1α using sh-or
si-RNA. Once stable knock-outs have been cloned, the cells can be examined for
alterations in differentiation and in their responses to hypoxia using the five endpoints of
differentiation as discussed previously. At the same time, the cells can be evaluated for
HIF-2α induction. If HIF-2α expression increases in knock-out cells it will support the
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theory that HIF-1 and HIF-2 have redundant functions during development and only
diverge in adult tissues. The endpoints of differentiation should then be monitored
closely for changes that would indicate any differences in function between the
homologs.
It is possible that HIF-2α will not be up-regulated after silencing of HIF-1α,
indicating that HIF-2α plays no role in the differentiation of Rcho-1 trophoblasts.
Further, the functions of HIF-1α during differentiation can be more fully examined
without having to consider the contributions of HIF-2α. If no HIF-2α is present after
knock-out of HIF-1α, changes in endpoints can be examined to characterize the exact role
of HIF-1α in controlling Rcho-1 trophoblast differentiation. Studies examining
trophoblast differentiation with sh/si RNA for HIF-1α may also lead to the discovery of
other proteins that play a role in certain aspects of differentiation that are sensitive to
hypoxia but HIF-1 independent.
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CONCLUSIONS
The complex role of HIF-1α and HIF-2α in the development of the placenta has
not been fully elucidated. Though other studies have shown a lack of HIF-2α activity in
murine embryonic stem cells, it remains necessary to determine at what level HIF-2α is
regulated in Rcho-1 trophoblasts. Preliminary studies showed mRNA expression at all
levels of hypoxia, supporting other studies. Though no protein was detected in nuclear
extracts of Rcho-1 cells cultured in hypoxia, further studies will be needed to clarify the
expression and activity of HIF-2α in Rcho-1 trophoblasts and what role, if any, it plays in
differentiation.
The finding that the promoter regions of the luciferase constitutive reporters
contain a myriad of consensus sequences has broad implications. A number of stressors
and treatments have the potential to induce these promoters, making them unsuitable as
control reporters in a variety of situations. Previous studies have reported activation of
constitutive reporters in response to steroid treatment, stimulation with
lipopolysaccharide, GATA transcription factors, and stress-activated MAP protein
kinases [65-69, 71-73]. Several other plasmids that are commonly used as control
reporters for transfection studies are also under the control of CMV or SV40 promoters,
including the enhanced green fluorescent protein (EGFP)-N1 plasmid,and the lacz
plasmid [39-40, 43]. These reporters also have the potential for induction by
experimental treatments and should also be used cautiously as controls to normalize for
transfection efficiency. The mechanisms of hypoxic induction have not been fully
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characterized and may include elements not discussed here. Therefore, it is vitally
important to use the split transfection assay to normalize for transfection efficiency when
using luciferase assays in hypoxia or when using treatments that may induce a stress or
hormone response.
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